Evaluation of an 111In-DOTA-rhenium cyclized α-MSH analog: A novel cyclic-peptide analog with improved tumor-targeting properties

Journal of Nuclear Medicine

Volumn 42, Issue 12, 2001, Pages 1847-1855

  Chen, J Q ^a   Cheng, Z ^a   Owen, N K ^a   Hoffman, T J ^a   Miao, Y ^a   Jurisson, S S ^a   Quinn, T P ^a  

^a University of Missouri   (United States)

Author keywords

melanocyte stimulating hormone; 111In labeling; Melanoma targeting; Metal cyclization; Peptide

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; ALPHA INTERMEDIN; CYSTEINE; DISULFIDE; INDIUM 111; PHENYLALANINE; RHENIUM;

ARTICLE; BINDING AFFINITY; BLOOD; CONTROLLED STUDY; DOSE RESPONSE; ISOTOPE LABELING; KIDNEY CLEARANCE; LIVER; LUNG; MELANOMA; MUSCLE; NONHUMAN; PRIORITY JOURNAL; RADIATION DETECTION; RADIOACTIVITY; RECEPTOR BINDING;

ALPHA-MSH; ANIMALS; FEMALE; INDIUM RADIOISOTOPES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; ORGANOMETALLIC COMPOUNDS; RADIOPHARMACEUTICALS; RHENIUM; TISSUE DISTRIBUTION;

EID: 0035659290     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. The use of a chelating derivative of alpha-melanocyte stimulating hormone for the clinical imaging of malignant melanoma
2. Receptor-mediated cytotoxicity of α-MSH fragments containing melphalan in a human melanoma cell line
3. Cloning and functional characterization of a family of receptors for the melanotropin peptides
4. Characterization of receptors for alphamelanocyte stimulating hormone on human melanoma cells
5. Melanotropin receptors demonstrated in situ in human melanoma
6. Specific receptors for alpha-melanocyte stimulating hormone are widely distributed in tissues of rodents
7. Enhanced binding and inertness to dehalogenation of α-melanotropin peptides labeled using N-succinimidyl 3-iodobenzoate
8. 7]-α-MSH, an α-melanocyte stimulating hormone analog
9. A chelating derivative of alpha-melanocyte stimulating hormone as a potential imaging agent for malignant melanoma
10. 111In-DPTA-labeled analogs of alpha-melanocyte-stimulating hormone for melanoma targeting: Receptor binding in vitro and in vivo
11. Design and characterization of alpha-melanotropin peptide analogs cyclized though rhenium and metal coordination
12. 99mTc/188Re labeled alpha melanocyte stimulating hormone analogs for specific melanoma targeting
13. 99mTc labeled alpha-melanotropin peptides
14. 99mTc-labeled cyclic alpha-melanocyte stimulating hormone peptide analogs
15. Radio-receptor assay for α-MSH using mouse B16 melanoma cells
16. 4-Norleucine, 7-D-phenylalanine-α-melanocyte-stimulating hormone: A highly potent α-melanotropin with ultralong biological activity
17. 7]α-MSH in B16 melanoma cells
18. Homologous and heterologous regulation of α-melanocyte-stimulating hormone receptor in human and mouse melanoma cell lines
19. Factors influencing the in vivo pharmacokinetics of peptides and antibody fragments: The pharmacokinetics of two PET-labeled low molecular weight proteins
20. Studies on renal tubular protein reabsorption: Partial and near complete inhibition by certain amino acids
21. Renal reabsorption of amino acids
22. 111In-DTPA-octreotide in the same patients: Biodistribution, kinetics, organ and tumor uptake
23. Optimized conditions for chelation of yttrium-90-DOTA immunoconjugates
24. 177Lu]α- [2-(4-aminophenyl)ethyl]-1,4,7,10-tetraaza-cyclododecane-1,4,7,10-tetraacetic acid-CC49 Fab radioimmunoconjugate
25. 203Pb labeled monoclonal antibodies
26. Improved in vivo stability and tumor targeting of bismuth-labeled antibody
27. Targeted proteins for diagnostic imaging: Does chemistry make a difference?